T1	Participants 54 161	metoprolol in combination with hydrochlorothiazide and hydralazine in an unselected hypertensive population
T2	Participants 164 279	One hundred nineteen patients with essential hypertension (96 completing six months and 92 a one year study period)
T3	Participants 554 614	Blood pressure reduction was significant in these all groups
T4	Participants 1133 1303	Antihypertensive drug treatment may cause some biochemical changes and those changes seem to be smallest patients treated with combination of beta-blocker and hydralazine
T5	Participants 1076 1118	individual response to single drug therapy
